Central sleep apnea treated by a constant low-dose CO2 supplied by a novel device

A novel device using a special mask was developed and proved that CO 2 therapy using the device could eliminate central sleep apnea (CSA) events and improve sleep quality including reducing arousal index in patients with heart failure. The device would become a useful clinical treatment for heart failure patients with CSA.